Italy Medicines Traceability Compliance: Preparing for the NMVO Italia Enforcement Phase

Italy is in a critical transition toward full alignment with the EU Falsified Medicines Directive. Here is what Marketing Authorization Holders, contract manufacturing organizations, and parallel distributors need to prepare before 8 February 2027 and how SoftGroup helps you get there with confidence.

Key takeaways:

  • Italy is replacing its national Bollino system and aligning with the EU verification model under Regulation (EU) 2016/161.
  • The stabilization period runs from 9 February 2025 to 8 February 2027 – use it to prepare packaging, data, systems, and partners.
  • Action is required across five fronts: packaging artwork, master and serialization data, system integration, NMVO Italia onboarding, and authority reporting.
  • SoftGroup supports companies end-to-end through SATT PLATFORM® and Level 1–5 serialization expertise with  22+ years in regulated pharma markets.

Update — 11 May 2026

Italy’s National Medicines Verification System (NMVS) is now officially connected to the EMVS production environment (EU-HUB).

MAHs (AIC holders) and On-Boarding Partners (OBPs) are now invited to begin:

  • Product Master Data loading to NMVO Italia
  • Artwork development including the GS1 Data Matrix, the “Allegato B” safety device, and the anti-tampering feature

Batch release under the stabilization period will initially run through a dedicated pilot — “Pilota Fase 2” — with MAH enrollment coordinated by pharma industry associations. Operational guidance will be issued by the Tavolo Tecnico di Monitoraggio established under the Italian Ministerial Decree of 4 March 2025.

Sources: Italian Ministry of Health Legislative Decree 10/2025, Art. 13(4) · Ministerial Decree 20 May 2025, Art. 6 · NMVO Italia official channel.

What this means for you: the working window started on 11 May 2026. You now have ~21 months to be fully aligned by 8 February 2027.

Why Italy FMD compliance matters now

Italy is the only EU market replacing a long-standing national Bollino system while transitioning to the EU Falsified Medicines Directive framework. That makes the Italian rollout uniquely structured and uniquely demanding for any company that places medicines on the Italian market.

For Marketing Authorization Holders (MAHs), contract manufacturing organizations (CMOs), and parallel distributors, the impact extends well beyond artwork updates. It touches reliable data management, system readiness, partner coordination, and clear compliance workflows.

The two-year stabilization window is not a grace period. It is the working window. Companies that begin preparation early reduce the risk of packaging rework, incomplete serialization data, delayed NMVO Italia onboarding, and verification issues as the 2027 deadline approaches.

whitepaper

Detailed Italy Pharmaceutical Serialization Roadmap

Download the Whitepaper

What is changing in Italy?

Italy is aligning its national medicines traceability framework with the European verification model introduced by the EU Falsified Medicines Directive and Commission Delegated Regulation (EU) 2016/161.

The EU framework requires two safety features on the outer packaging of medicinal products:

  • A unique identifier, encoded in a 2D Data Matrix, that enables verification of authenticity and identification of an individual pack.
  • An anti-tampering device that helps verify whether the packaging has been opened or altered.

For Italy specifically, this transition retains country-specific requirements during the stabilization period (9 February 2025 → 8 February 2027), while pharmaceutical companies move toward the harmonized European verification model.

The five readiness fronts for Italy FMD compliance

A practical checklist of what to prepare and validate before the deadline.

Implement the 2D Data Matrix, unique identifier, and anti-tampering device on outer packaging, aligned with Italian transition requirements.

Establish reliable master data, batch data, and serial-number governance across products, sites, and markets.

Connect packaging-line systems, ERP, WMS, and partner platforms so serialized data flows correctly across the supply chain.

Complete company registration, the entrance fee, contract signature, and annual fee payment where applicable.

Prepare accurate, structured serialization data for national traceability and the European verification system.

How SoftGroup supports Italy traceability compliance

 

SoftGroup delivers end-to-end serialization, aggregation, and traceability capabilities purpose-built for regulated pharmaceutical markets. Our solutions span hardware, line-level software, enterprise management, partner integration, and regulatory connectivity.

SATT PLATFORM® — Levels 1 to 5

  • Level 1–2: Production-level serialization. Validated solutions for printing, verification, rejection handling, rework, aggregation, and structured data exchange with enterprise systems.
  • Level 3: Centralized serialization control. SATT PLATFORM® manages product data, batch data, serial numbers, production events, and compliance workflows across lines, sites, and partners.
  • Level 4: Partner and system integration. Reliable data flow with ERP, WMS, CMOs, MAHs, logistics partners, and external systems, built on the GS1 EPCIS standard.
  • Level 5 : Authority reporting readiness. Secure, compliant connection to national systems and the European verification system, maintained to reflect evolving regulatory changes.

 

Expert support through the transition

 

Compliance is not just a technology question; it is an execution question. SoftGroup combines regulatory understanding with practical serialization experience, supporting customers through implementation, validation, NMVO Italia onboarding preparation, and operational alignment.

Why early preparation matters

Italy’s transition affects packaging artwork, line-level serialization, master data management, partner communication, system integration, verification processes, and compliance reporting readiness. Each one is a discrete project. Together, they are an operational program — and programs run smoother when they start early.

Suggested timeline

  • Now → Q3 2026. Assess current setup. Identify gaps across packaging, data, systems, and partners. Confirm NMVO Italia onboarding scope and timeline.
  • Q3 2026 → Q1 2027. Implement and validate serialization, aggregation, and data exchange flows. Run pilots with CMOs and supply-chain partners. Stabilize master data.
  • Through 8 February 2027. Operational rollout. Continuous data quality monitoring. Full alignment with the EU verification system and Italian transition requirements.

Prepare your Italy compliance roadmap with SoftGroup

Italy’s stabilization period is already active. Let’s assess your packaging, data, system, and partner readiness and build a structured roadmap to 8 February 2027.

Request a Demo